Quick Summary
Unigrilin 20mg Injection
Last updated on 29 Aug 2026 | 11:33 AM (IST)
₹2695
MRP: ₹3500
(You Save ₹805)
1 VIAL(s) OF 10ML
Unigrilin 20mg Injection
Salt Composition
EPTIFIBATIDEMarketer
UNITED BIOTECH PVT LTD
Prepaid Only. Non-Returnable.
23% OFF
₹2695
MRP: ₹3,500.00
Inclusive of all taxes
23% Off
Salt Composition
EPTIFIBATIDEMarketer
UNITED BIOTECH PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.


Introduction
Unigrilin 20mg Injection is a blood thinner used to prevent harmful blood clots in people with heart problems. It is commonly prescribed during procedures like angioplasty and in patients with unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) to keep blood flowing smoothly in the heart.
It contains Eptifibatide, a medicine that belongs to a group of drugs called glycoprotein IIb/IIIa inhibitors. These medicines work by stopping platelets (blood cells involved in clotting) from sticking together, reducing the risk of heart attack or other complications.
Uses
Unigrilin injection uses are mainly in the following conditions:
-
Unstable Angina
-
Prevention of Blood Clots
-
Prevention of Heart Attack
-
During Coronary Angioplasty or Stent Placement
How Unigrilin Injection Works
Unigrilin Injection is an antiplatelet medicine. It works by preventing platelets from clumping together, thus lowering the chance of clot formation in blood vessels. This helps maintain steady blood flow, especially during procedures like angioplasty.
Interaction of Unigrilin 20mg Injection with other drugs
Tell your doctor about all the medicines you take, especially:
-
Apixaban, Dabigatran, Rivaroxaban – may increase bleeding risk
-
Desvenlafaxine, Dasatinib – may increase the risk of side effects
Avoid combining Unigrilin with other blood thinners unless specifically advised.
Storage Conditions
-
Store Unigrilin 20 injection at 20°C to 25°C
-
Keep away from heat, light, and moisture
-
Do not freeze
-
Keep out of reach of children
How to Use Unigrilin Injection
This medicine is given by a healthcare professional through a drip (intravenous infusion). Do not self-administer. Your doctor will decide the dose and duration based on your condition.
Safety Advice for Unigrilin 20mg Injection
Breast Feeding
Unigrilin 20mg injection's compatibility with breastfeeding is not well established. Consult a doctor if you are a breast feeding women before taking this medication.
Alcohol
Excessive alcohol consumption can increase the risk of bleeding. It is advisable to avoid excessive alcohol intake while receiving Unigrilin 20mg injection, as alcohol can interact with the medication's effects on blood clotting.
Liver
If you have a history of liver conditions, it's important to consult your doctor before receiving Unigrilin 20mg injection.
Lungs
Unigrilin 20mg injection should be used cautiously in individuals with severe lung disease. If you have any lung conditions, consult a doctor before starting treatment.
Driving
Unigrilin 20mg injection itself is not likely to directly affect your ability to drive. However, if you experience side effects like dizziness, weakness, or other symptoms, use caution and consult your doctor.
Pregnancy
Unigrilin 20mg injection's safety during pregnancy has not been well studied. If you are pregnant or planning to become pregnant, consult your doctor before using this medication.
Side Effects of Unigrilin 20mg Injection
Unigrilin 20mg/10ml Injection causes some side effects like all medications, although not everyone will experience them.
Common Side Effects
-
Bleeding (including at injection site)
-
Low blood pressure
-
Nausea
-
Headache
-
Fever
Serious Side Effects (Seek Immediate Help)
-
Severe bleeding
-
Thrombocytopenia (low platelet count)
-
Allergic reactions (rash, swelling, breathing difficulty)
Expert Tips
-
This injection is always given by a healthcare professional, usually through a drip into your vein during hospital treatment.
-
It may increase your risk of bleeding. Use caution when shaving, cutting nails, or handling sharp objects.
-
Tell your doctor immediately if you notice any unusual bleeding, such as blood in your urine, stool, vomit, or bleeding gums.
-
Let your doctor know about all other medications you are taking, including blood thinners and pain relievers, to avoid potential interactions.
FAQs about Unigrilin 20mg Injection
Q1.
What happens if I miss a dose of Unigrilin 20mg injection?
Unigrilin 20mg injection is administered by healthcare professionals during specific medical procedures. If you're concerned about missing a dose, discuss it with your healthcare provider.
Q2.
Can I eat normally while on Unigrilin 20mg injection?
There are generally no specific dietary restrictions while on Unigrilin 20mg injection. However, it's always a good idea to follow a balanced diet and discuss any dietary changes with your healthcare provider.
Q3.
Is the action of Unigrilin 20mg injection reversible?
Unigrilin 20mg injection's effects on platelets are reversible once the medication is stopped. However, the time it takes for platelet function to return to normal can vary.
Q4.
Can I receive dental procedures while on Unigrilin 20mg injection?
Dental procedures can increase bleeding risk. Inform your dentist about Unigrilin 20mg injection use to determine the best approach and timing for dental work.
Q5.
What should I do if I experience side effects during Unigrilin 20mg injection treatment?
If you experience side effects, especially severe ones like significant bleeding or allergic reactions, seek immediate medical attention and inform your healthcare provider.
Fact Box of Unigrilin 20mg Injection
Molecule name: Eptifibatide | Therapeutic class: Antiplatelet Agents |
Pharmacological class: Glycoprotein IIb/IIIa inhibitors. | Indications: 1. Coronary angioplasty and stent placement 2. Acute coronary syndrome (ACS) |
References
- GlaxoSmithKline UK Limited, Electronic medicines compendium (EMC) [Revised on 21 May 2021] [Accessed on 18th Dec 2023], https://www.medicines.org.uk/emc/product/3889/smpc
- Kerstin Hogg and Jeffrey I. Weitz, Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs, Goodman and Gilman’s Pharmacological Basis of Therapeutics, 585-603
- Merck & Co.Inc.US Food and Drug Administration, [Revised on 2nd 2021] [Accessed on 18th August 2023], /https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020718s039lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Sakshi Anil More
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Aug 2026 | 11:33 AM (IST)

Want to know more?
Read Our Editorial Policy








